BADGER METER INC (BMI) Stock Fundamental Analysis

NYSE:BMI • US0565251081

160.6 USD
+5.72 (+3.69%)
Last: Feb 17, 2026, 03:39 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to BMI. BMI was compared to 122 industry peers in the Electronic Equipment, Instruments & Components industry. BMI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BMI has a correct valuation and a medium growth rate. These ratings would make BMI suitable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • BMI had positive earnings in the past year.
  • BMI had a positive operating cash flow in the past year.
  • BMI had positive earnings in each of the past 5 years.
  • Each year in the past 5 years BMI had a positive operating cash flow.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1.2 Ratios

  • BMI has a Return On Assets of 14.55%. This is amongst the best in the industry. BMI outperforms 95.08% of its industry peers.
  • BMI has a Return On Equity of 19.86%. This is amongst the best in the industry. BMI outperforms 90.16% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 16.73%, BMI belongs to the top of the industry, outperforming 94.26% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BMI is significantly above the industry average of 8.95%.
  • The last Return On Invested Capital (16.73%) for BMI is above the 3 year average (16.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.55%
ROE 19.86%
ROIC 16.73%
ROA(3y)14.26%
ROA(5y)13.05%
ROE(3y)19.46%
ROE(5y)17.71%
ROIC(3y)16.29%
ROIC(5y)15.06%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 15.45%, BMI belongs to the top of the industry, outperforming 92.62% of the companies in the same industry.
  • BMI's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 20.01%, BMI belongs to the top of the industry, outperforming 96.72% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BMI has grown nicely.
  • The Gross Margin of BMI (41.68%) is better than 71.31% of its industry peers.
  • In the last couple of years the Gross Margin of BMI has remained more or less at the same level.
Industry RankSector Rank
OM 20.01%
PM (TTM) 15.45%
GM 41.68%
OM growth 3Y9.04%
OM growth 5Y5.48%
PM growth 3Y9.53%
PM growth 5Y5.93%
GM growth 3Y2.33%
GM growth 5Y1.07%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

7

2. Health

2.1 Basic Checks

  • BMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • BMI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BMI has more shares outstanding
  • BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.78
WACC9.39%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.36 indicates that BMI has no problem at all paying its short term obligations.
  • BMI has a better Current ratio (3.36) than 69.67% of its industry peers.
  • A Quick Ratio of 2.36 indicates that BMI has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.36, BMI is doing good in the industry, outperforming 63.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.36
Quick Ratio 2.36
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 13.48% over the past year.
  • The Earnings Per Share has been growing by 23.07% on average over the past years. This is a very strong growth
  • The Revenue has grown by 10.90% in the past year. This is quite good.
  • Measured over the past years, BMI shows a quite strong growth in Revenue. The Revenue has been growing by 16.59% on average per year.
EPS 1Y (TTM)13.48%
EPS 3Y28.35%
EPS 5Y23.07%
EPS Q2Q%9.62%
Revenue 1Y (TTM)10.9%
Revenue growth 3Y17.46%
Revenue growth 5Y16.59%
Sales Q2Q%7.57%

3.2 Future

  • BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.55% yearly.
  • BMI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.18% yearly.
EPS Next Y7.84%
EPS Next 2Y8.28%
EPS Next 3Y9.04%
EPS Next 5Y9.55%
Revenue Next Year5.42%
Revenue Next 2Y5.79%
Revenue Next 3Y6.5%
Revenue Next 5Y7.18%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.46, BMI can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of BMI indicates a somewhat cheap valuation: BMI is cheaper than 65.57% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of BMI to the average of the S&P500 Index (27.19), we can say BMI is valued slightly more expensively.
  • Based on the Price/Forward Earnings ratio of 31.03, the valuation of BMI can be described as expensive.
  • Based on the Price/Forward Earnings ratio, BMI is valued a bit cheaper than 60.66% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, BMI is valued at the same level.
Industry RankSector Rank
PE 33.46
Fwd PE 31.03
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 67.21% of the companies in the same industry are more expensive than BMI, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, BMI is valued a bit cheaper than the industry average as 73.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.89
EV/EBITDA 19.9
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BMI does not grow enough to justify the current Price/Earnings ratio.
  • BMI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.27
PEG (5Y)1.45
EPS Next 2Y8.28%
EPS Next 3Y9.04%

6

5. Dividend

5.1 Amount

  • BMI has a Yearly Dividend Yield of 1.01%.
  • BMI's Dividend Yield is rather good when compared to the industry average which is at 0.47. BMI pays more dividend than 86.07% of the companies in the same industry.
  • With a Dividend Yield of 1.01, BMI pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.01%

5.2 History

  • The dividend of BMI is nicely growing with an annual growth rate of 16.16%!
  • BMI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • BMI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)16.16%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • 30.73% of the earnings are spent on dividend by BMI. This is a low number and sustainable payout ratio.
  • BMI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.73%
EPS Next 2Y8.28%
EPS Next 3Y9.04%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (2/17/2026, 3:39:34 PM)

160.6

+5.72 (+3.69%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)01-28
Earnings (Next)04-15
Inst Owners102%
Inst Owner Change3.94%
Ins Owners0.51%
Ins Owner Change1.84%
Market Cap4.73B
Revenue(TTM)916.66M
Net Income(TTM)141.63M
Analysts75.29
Price Target184.44 (14.84%)
Short Float %6.99%
Short Ratio5.72
Dividend
Industry RankSector Rank
Dividend Yield 1.01%
Yearly Dividend1.48
Dividend Growth(5Y)16.16%
DP30.73%
Div Incr Years18
Div Non Decr Years18
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.25%
Min EPS beat(2)-3.05%
Max EPS beat(2)3.55%
EPS beat(4)2
Avg EPS beat(4)3.71%
Min EPS beat(4)-7.6%
Max EPS beat(4)21.92%
EPS beat(8)4
Avg EPS beat(8)4.09%
EPS beat(12)8
Avg EPS beat(12)6.31%
EPS beat(16)10
Avg EPS beat(16)5.24%
Revenue beat(2)1
Avg Revenue beat(2)-2.61%
Min Revenue beat(2)-5.83%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-5.83%
Max Revenue beat(4)0.62%
Revenue beat(8)4
Avg Revenue beat(8)0.46%
Revenue beat(12)7
Avg Revenue beat(12)2.21%
Revenue beat(16)10
Avg Revenue beat(16)2.16%
PT rev (1m)-17.14%
PT rev (3m)-18.74%
EPS NQ rev (1m)-7.07%
EPS NQ rev (3m)-6.52%
EPS NY rev (1m)-5.4%
EPS NY rev (3m)-5.59%
Revenue NQ rev (1m)-4.62%
Revenue NQ rev (3m)-4.62%
Revenue NY rev (1m)-2.83%
Revenue NY rev (3m)-2.83%
Valuation
Industry RankSector Rank
PE 33.46
Fwd PE 31.03
P/S 5.16
P/FCF 27.89
P/OCF 25.76
P/B 6.64
P/tB 13.18
EV/EBITDA 19.9
EPS(TTM)4.8
EY2.99%
EPS(NY)5.18
Fwd EY3.22%
FCF(TTM)5.76
FCFY3.58%
OCF(TTM)6.23
OCFY3.88%
SpS31.1
BVpS24.2
TBVpS12.19
PEG (NY)4.27
PEG (5Y)1.45
Graham Number51.13
Profitability
Industry RankSector Rank
ROA 14.55%
ROE 19.86%
ROCE 22.29%
ROIC 16.73%
ROICexc 23.07%
ROICexgc 56.71%
OM 20.01%
PM (TTM) 15.45%
GM 41.68%
FCFM 18.51%
ROA(3y)14.26%
ROA(5y)13.05%
ROE(3y)19.46%
ROE(5y)17.71%
ROIC(3y)16.29%
ROIC(5y)15.06%
ROICexc(3y)25.01%
ROICexc(5y)21.97%
ROICexgc(3y)48.48%
ROICexgc(5y)42.11%
ROCE(3y)21.7%
ROCE(5y)20.07%
ROICexgc growth 3Y19.06%
ROICexgc growth 5Y16.93%
ROICexc growth 3Y7.68%
ROICexc growth 5Y9.3%
OM growth 3Y9.04%
OM growth 5Y5.48%
PM growth 3Y9.53%
PM growth 5Y5.93%
GM growth 3Y2.33%
GM growth 5Y1.07%
F-Score6
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 40.56%
Cap/Sales 1.53%
Interest Coverage 250
Cash Conversion 84.26%
Profit Quality 119.8%
Current Ratio 3.36
Quick Ratio 2.36
Altman-Z N/A
F-Score6
WACC9.39%
ROIC/WACC1.78
Cap/Depr(3y)41.03%
Cap/Depr(5y)33.95%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.43%
Profit Quality(3y)113.19%
Profit Quality(5y)117.47%
High Growth Momentum
Growth
EPS 1Y (TTM)13.48%
EPS 3Y28.35%
EPS 5Y23.07%
EPS Q2Q%9.62%
EPS Next Y7.84%
EPS Next 2Y8.28%
EPS Next 3Y9.04%
EPS Next 5Y9.55%
Revenue 1Y (TTM)10.9%
Revenue growth 3Y17.46%
Revenue growth 5Y16.59%
Sales Q2Q%7.57%
Revenue Next Year5.42%
Revenue Next 2Y5.79%
Revenue Next 3Y6.5%
Revenue Next 5Y7.18%
EBIT growth 1Y16.14%
EBIT growth 3Y28.08%
EBIT growth 5Y22.98%
EBIT Next Year29.76%
EBIT Next 3Y15.99%
EBIT Next 5Y11.6%
FCF growth 1Y19.31%
FCF growth 3Y30.38%
FCF growth 5Y16.08%
OCF growth 1Y18.49%
OCF growth 3Y30.61%
OCF growth 5Y15.45%

BADGER METER INC / BMI FAQ

What is the fundamental rating for BMI stock?

ChartMill assigns a fundamental rating of 7 / 10 to BMI.


Can you provide the valuation status for BADGER METER INC?

ChartMill assigns a valuation rating of 4 / 10 to BADGER METER INC (BMI). This can be considered as Fairly Valued.


Can you provide the profitability details for BADGER METER INC?

BADGER METER INC (BMI) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for BMI stock?

The Earnings per Share (EPS) of BADGER METER INC (BMI) is expected to grow by 7.84% in the next year.


How sustainable is the dividend of BADGER METER INC (BMI) stock?

The dividend rating of BADGER METER INC (BMI) is 6 / 10 and the dividend payout ratio is 30.73%.